Literature DB >> 29751266

Controlled hydrothermal synthesis of bismuth oxychloride/bismuth oxybromide/bismuth oxyiodide composites exhibiting visible-light photocatalytic degradation of 2-hydroxybenzoic acid and crystal violet.

Ciao-Wei Siao1, Hung-Lin Chen2, Li-Wen Chen1, Jia-Lin Chang1, Tsung-Wen Yeh1, Chiing-Chang Chen3.   

Abstract

This paper presents an unprecedented systematic synthetic study of a controlled hydrothermal method for the preparation of bismuth oxychloride/bismuth oxybromide/bismuth oxyiodide ternary composites (BiOxCly/BiOmBrn/BiOpIq). The pH, temperature, and KCl:KBr:KI molar ratio for the reactions were adjusted to control the compositions and morphologies of BiOxCly/BiOmBrn/BiOpIq composites. Scanning electron microscopy-energy dispersive X-ray spectroscopy, transmission electron microscopy, X-ray diffraction, ultraviolet-visible diffuse reflectance spectroscopy, Brunauer-Emmett-Teller specific surface areas, photoluminescence spectroscopy, and X-ray photoelectron spectroscopy, and electron paramagnetic resonance spectroscopy were applied to the products. The photocatalytic activities of dispersions were examined by monitoring the 2-hydroxybenzoic acid (HBA) and crystal violet concentrations. Various scavengers demonstrated quenching effects. O2- was crucial to HBA degradation, whereas h+ and OH played minor roles in HBA degradation. This text hypothesizes possible photodegradation mechanisms.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-Hydroxybenzoic acid; BiO(x)Cl(y)/BiO(m)Br(n)/BiO(p)I(q); Composites; Crystal violet; Photocatalysis

Year:  2018        PMID: 29751266     DOI: 10.1016/j.jcis.2018.04.097

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  1 in total

1.  Visible light assisted photocatalytic degradation of crystal violet dye and electrochemical detection of ascorbic acid using a BiVO4/FeVO4 heterojunction composite.

Authors:  Muhammad Munir Sajid; Sadaf Bashir Khan; Naveed Akthar Shad; Nasir Amin; Zhengjun Zhang
Journal:  RSC Adv       Date:  2018-06-27       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.